Healthcare

Odds are up for an impending upward reversal.
 Hepatitis C therapies are the pacesetters.
There could be a lot to lose when selling long-term investments.
The acquisition is a symbol of a much bigger trend.
There has been huge progress in treating this lethal disease.

A Trio of Healthcare Plays Real Money Pro($)

Here's how I'd trade this biotech fund, Incyte and Immunogen.
Amgen's gain is pure insanity from a stock picker's point of view.
Amid the basket's impressive performance, I'm adding Minerva.
The post-earnings trend says the stock will drop after the report.
What to do when central bankers tell you to cut risk.

Columnist Conversations

Market continues to hold onto impressive gains in the last day of a roller coaster trading month. This month ...
UPS is bumping up against a very heavy layer of resistance today. The stock's 1.6% gain has pushed shar...
The 244 area is the first major target off the 10/16 low. It's still a good idea to trail up stops as you go,...
Time to ratchet up stops if you took anything in BIDU. See the chart below. View Char...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.